Atossa Therapeutics, Inc. (ATOS)
2.42
-0.04
(-1.63%)
USD |
NASDAQ |
Oct 08, 16:00
2.42
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics Price to Book Value : 0.9001 for Oct. 8, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 0.9001 |
| October 07, 2026 | 0.915 |
| October 06, 2026 | 0.9113 |
| October 05, 2026 | 0.9113 |
| October 02, 2026 | 0.8704 |
| October 01, 2026 | 0.8443 |
| September 30, 2026 | 0.7253 |
| September 29, 2026 | 0.7402 |
| September 28, 2026 | 0.729 |
| September 25, 2026 | 0.7067 |
| September 24, 2026 | 0.7625 |
| September 23, 2026 | 0.8108 |
| September 22, 2026 | 0.8406 |
| September 21, 2026 | 0.8369 |
| September 18, 2026 | 0.8257 |
| September 17, 2026 | 0.8927 |
| September 16, 2026 | 0.9001 |
| September 15, 2026 | 0.8815 |
| September 14, 2026 | 0.9224 |
| September 11, 2026 | 0.9336 |
| September 10, 2026 | 0.8704 |
| September 09, 2026 | 0.8927 |
| September 08, 2026 | 0.9354 |
| September 04, 2026 | 0.9373 |
| September 03, 2026 | 0.941 |
| Date | Value |
|---|---|
| September 02, 2026 | 0.915 |
| September 01, 2026 | 0.9001 |
| August 31, 2026 | 0.9299 |
| August 28, 2026 | 0.9596 |
| August 27, 2026 | 0.9819 |
| August 26, 2026 | 0.9857 |
| August 25, 2026 | 0.9968 |
| August 24, 2026 | 0.9819 |
| August 21, 2026 | 0.9447 |
| August 20, 2026 | 0.9633 |
| August 19, 2026 | 0.9819 |
| August 18, 2026 | 0.9633 |
| August 17, 2026 | 1.038 |
| August 14, 2026 | 0.9671 |
| August 13, 2026 | 0.9522 |
| August 12, 2026 | 0.8741 |
| August 11, 2026 | 0.8778 |
| August 10, 2026 | 0.8815 |
| August 07, 2026 | 0.8778 |
| August 06, 2026 | 0.9001 |
| August 05, 2026 | 0.8889 |
| August 04, 2026 | 0.8592 |
| August 03, 2026 | 0.8071 |
| July 31, 2026 | 0.7699 |
| July 30, 2026 | 0.8146 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Immix Biopharma, Inc. | 2.903 |
| ACADIA Pharmaceuticals, Inc. | 2.580 |
| Alnylam Pharmaceuticals, Inc. | 22.17 |
| Savara, Inc. | 6.906 |
| Vericel Corp. | 5.538 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0041 |
| Price | 2.42 |
| Earnings Yield | -179.5% |
| Market Cap | 24.15M |
| PEGY Ratio | -0.0041 |